Experienced in Femoral Nerve Dysfunction

Morten H. Bestle

Copenhagen, DK 
Clinical Trials:Currently Recruiting for 1 Trial
Experienced in Femoral Nerve Dysfunction
Copenhagen, DK 
OverviewLocationsClinical Research

Overview

Morten Bestle practices in Copenhagen, Denmark. Mr. Bestle is rated as an Experienced expert by MediFind in the treatment of Femoral Nerve Dysfunction. His top areas of expertise are Sepsis, Cerebral Hypoxia, Severe Acute Respiratory Syndrome (SARS), and COVID-19.

His clinical research consists of co-authoring 131 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Femoral Nerve Dysfunction.

Gender
Male

Locations

Copenhagen, Denmark
Other Locations
Hillerod, Denmark
Herlev, Denmark
Odense, Denmark
Hvidovre, Denmark
Herning, Denmark
Slagelse, Denmark
Hilleroed, Denmark
Glostrup, Denmark

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Goal Directed Fluid Removal With Furosemide in Intensive Care Patients With Fluid Overload - A Randomised, Blinded, Placebo-controlled Trial (GODIF).
Goal Directed Fluid Removal With Furosemide in Intensive Care Patients With Fluid Overload - A Randomised, Blinded, Placebo-controlled Trial (GODIF).
Enrollment Status: Recruiting
Publish Date: February 06, 2025
Intervention Type: Drug
Study Phase: Phase 4
Efficacy and Safety of 72-hour Infusion of Prostacyclin (1 Nanogram(ng)/ Kilo(kg)/Minute(Min)) in Patients With COVID-19 Induced Pulmonary Endotheliopathy
Efficacy and Safety of 72-hour Infusion of Prostacyclin (1 Nanogram(ng)/ Kilo(kg)/Minute(Min)) in Patients With COVID-19 Induced Pulmonary Endotheliopathy
Enrollment Status: Completed
Publish Date: May 07, 2024
Intervention Type: Drug
Study Drug: Iloprost
Study Phase: Phase 2
Efficacy and Safety of 72-hour Infusion of Prostacyclin (1 Nanogram(ng)/Kilo(kg)/Minute(Min)) in Patients With Septic Shock Induced Endotheliopathy - a Multicentre Randomized, Placebo-controlled, Blinded, Investigator-initiated Trial
Efficacy and Safety of 72-hour Infusion of Prostacyclin (1 Nanogram(ng)/Kilo(kg)/Minute(Min)) in Patients With Septic Shock Induced Endotheliopathy - a Multicentre Randomized, Placebo-controlled, Blinded, Investigator-initiated Trial
Enrollment Status: Completed
Publish Date: May 07, 2024
Intervention Type: Drug
Study Drug: Iloprost
Study Phase: Phase 2/Phase 3
Safety and Efficacy of Iloprost and Eptifibatide Co-administration Compared to Standard Therapy in Patients With Septic Shock - a Randomized, Controlled, Double-blind Investigator-initiated Trial
Safety and Efficacy of Iloprost and Eptifibatide Co-administration Compared to Standard Therapy in Patients With Septic Shock - a Randomized, Controlled, Double-blind Investigator-initiated Trial
Enrollment Status: Completed
Publish Date: April 24, 2017
Intervention Type: Drug
Study Phase: Phase 2
View 3 Less Clinical Trials

131 Total Publications

Hypernatremia in Hospitalised Adult Patients-A Scoping Review.
Hypernatremia in Hospitalised Adult Patients-A Scoping Review.
Journal: Acta anaesthesiologica Scandinavica
Published: July 15, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Bestle's expertise for a condition
ConditionClose
    View All 17 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile